Toll-like receptor 4 promotes high glucose-induced catabolic and inflammatory responses in chondrocytes in an NF-κB-dependent manner

Diabetes is an independent risk factor for knee osteoarthritis (OA), and hyperglycaemia-induced inflammation is considered to play an important role in their connection. The Toll-like receptor 4 (TLR4) regulates inflammatory responses in several pathological conditions including diabetes and OA. How...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Life sciences (1973) 2019-07, Vol.228, p.258-265
Hauptverfasser: Liang, Hongzhi, Wang, Huajun, Luo, Leifeng, Fan, Shuxin, Zhou, Li, Liu, Zhaoshu, Yao, Shujun, Zhang, Xiao, Zhong, Kaihua, Zhao, Hancheng, Zha, Zhengang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 265
container_issue
container_start_page 258
container_title Life sciences (1973)
container_volume 228
creator Liang, Hongzhi
Wang, Huajun
Luo, Leifeng
Fan, Shuxin
Zhou, Li
Liu, Zhaoshu
Yao, Shujun
Zhang, Xiao
Zhong, Kaihua
Zhao, Hancheng
Zha, Zhengang
description Diabetes is an independent risk factor for knee osteoarthritis (OA), and hyperglycaemia-induced inflammation is considered to play an important role in their connection. The Toll-like receptor 4 (TLR4) regulates inflammatory responses in several pathological conditions including diabetes and OA. However, its role in diabetes-associated OA is poorly understood. In this study, we found that TLR4 expression was higher in OA cartilage from patients with type 2 diabetes mellitus (T2DM) than that from non-T2DM patients. Similarly, its expression was induced in primary mouse chondrocytes treated with high glucose, which suggests that TLR4 upregulation in T2DM-associated OA cartilage may originate from hyperglycaemia stimulation. We further discovered that TLR4 promoted high glucose-induced catabolic and inflammatory responses in chondrocytes, and mechanistically, these effects could be explained by the exacerbated activation of the transcription factor nuclear factor kappa B (NF-κB) pathway, since its inhibition by Bay 11-7082 abrogated TLR4 effects on high glucose-treated chondrocytes. Taken together, these findings may reveal a promotive role of TLR4 in regulating hyperglycaemia-induced catabolism and inflammation in T2DM-associated OA, and also implicate that TLR4 inhibition might be of therapeutic significance in treating T2DM-associated OA.
doi_str_mv 10.1016/j.lfs.2019.04.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2204689251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320519302619</els_id><sourcerecordid>2244147850</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-3763f373fb54cd09e81fd029f30153de3d887b3c3f87604dbc3889c7e2fcc5563</originalsourceid><addsrcrecordid>eNp9kU1uFDEQRi0EIkPgAGyQJTZsuim37f4RKxIRQIpgE9ZWt13OeHDbjd2NNAfgUhyCM-FoAgsWrKyS3vepXI-Q5wxqBqx9fai9zXUDbKhB1MDYA7JjfTdU0HL2kOwAGlHxBuQZeZLzAQCk7PhjcsZhkLwVckd-3ETvK---Ik2ocVljooIuKc5xxUz37nZPb_2mY8bKBbNpNFSP6zhF7zQdg6EuWD_O81iSx9KRlxhySbpA9T4Gk6I-rqd5DPTTVfXr50VlcMFgMKx0HkPA9JQ8sqPP-Oz-PSdfrt7dXH6orj-__3j59rrSvGdrxbuWW95xO0mhDQzYM2ugGSwHJrlBbvq-m7jmtu9aEGYqsX7QHTZWaylbfk5enXrLB79tmFc1u6zR-zFg3LJqGhBtPzSSFfTlP-ghbimU7QolBBNdL6FQ7ETpFHNOaNWS3Dymo2Kg7hypgyqO1J0jBUIVRyXz4r55m2Y0fxN_pBTgzQnAcorvDpPK2mEop3fF0apMdP-p_w3TWKOB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2244147850</pqid></control><display><type>article</type><title>Toll-like receptor 4 promotes high glucose-induced catabolic and inflammatory responses in chondrocytes in an NF-κB-dependent manner</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Liang, Hongzhi ; Wang, Huajun ; Luo, Leifeng ; Fan, Shuxin ; Zhou, Li ; Liu, Zhaoshu ; Yao, Shujun ; Zhang, Xiao ; Zhong, Kaihua ; Zhao, Hancheng ; Zha, Zhengang</creator><creatorcontrib>Liang, Hongzhi ; Wang, Huajun ; Luo, Leifeng ; Fan, Shuxin ; Zhou, Li ; Liu, Zhaoshu ; Yao, Shujun ; Zhang, Xiao ; Zhong, Kaihua ; Zhao, Hancheng ; Zha, Zhengang</creatorcontrib><description>Diabetes is an independent risk factor for knee osteoarthritis (OA), and hyperglycaemia-induced inflammation is considered to play an important role in their connection. The Toll-like receptor 4 (TLR4) regulates inflammatory responses in several pathological conditions including diabetes and OA. However, its role in diabetes-associated OA is poorly understood. In this study, we found that TLR4 expression was higher in OA cartilage from patients with type 2 diabetes mellitus (T2DM) than that from non-T2DM patients. Similarly, its expression was induced in primary mouse chondrocytes treated with high glucose, which suggests that TLR4 upregulation in T2DM-associated OA cartilage may originate from hyperglycaemia stimulation. We further discovered that TLR4 promoted high glucose-induced catabolic and inflammatory responses in chondrocytes, and mechanistically, these effects could be explained by the exacerbated activation of the transcription factor nuclear factor kappa B (NF-κB) pathway, since its inhibition by Bay 11-7082 abrogated TLR4 effects on high glucose-treated chondrocytes. Taken together, these findings may reveal a promotive role of TLR4 in regulating hyperglycaemia-induced catabolism and inflammation in T2DM-associated OA, and also implicate that TLR4 inhibition might be of therapeutic significance in treating T2DM-associated OA.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2019.04.011</identifier><identifier>PMID: 30953645</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Animals ; Biocompatibility ; Biomedical materials ; Cartilage ; Cartilage diseases ; Catabolism ; Cells, Cultured ; Chondrocytes ; Chondrocytes - immunology ; Chondrocytes - pathology ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - immunology ; Diabetes Mellitus, Type 2 - pathology ; Glucose ; Glucose - immunology ; Health risks ; High glucose ; Humans ; Hyperglycemia ; Inflammation ; Inflammation - complications ; Inflammation - immunology ; Inflammation - pathology ; Inhibition ; Knee ; Male ; Mice, Inbred C57BL ; NF-kappa B - immunology ; NF-κB protein ; Osteoarthritis ; Osteoarthritis - complications ; Osteoarthritis - immunology ; Osteoarthritis - pathology ; Risk analysis ; Risk factors ; TLR4 protein ; Toll-like receptor 4 ; Toll-Like Receptor 4 - immunology ; Toll-like receptors ; Transcription activation ; Type 2 diabetes</subject><ispartof>Life sciences (1973), 2019-07, Vol.228, p.258-265</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier BV Jul 1, 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c381t-3763f373fb54cd09e81fd029f30153de3d887b3c3f87604dbc3889c7e2fcc5563</citedby><cites>FETCH-LOGICAL-c381t-3763f373fb54cd09e81fd029f30153de3d887b3c3f87604dbc3889c7e2fcc5563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0024320519302619$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30953645$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liang, Hongzhi</creatorcontrib><creatorcontrib>Wang, Huajun</creatorcontrib><creatorcontrib>Luo, Leifeng</creatorcontrib><creatorcontrib>Fan, Shuxin</creatorcontrib><creatorcontrib>Zhou, Li</creatorcontrib><creatorcontrib>Liu, Zhaoshu</creatorcontrib><creatorcontrib>Yao, Shujun</creatorcontrib><creatorcontrib>Zhang, Xiao</creatorcontrib><creatorcontrib>Zhong, Kaihua</creatorcontrib><creatorcontrib>Zhao, Hancheng</creatorcontrib><creatorcontrib>Zha, Zhengang</creatorcontrib><title>Toll-like receptor 4 promotes high glucose-induced catabolic and inflammatory responses in chondrocytes in an NF-κB-dependent manner</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>Diabetes is an independent risk factor for knee osteoarthritis (OA), and hyperglycaemia-induced inflammation is considered to play an important role in their connection. The Toll-like receptor 4 (TLR4) regulates inflammatory responses in several pathological conditions including diabetes and OA. However, its role in diabetes-associated OA is poorly understood. In this study, we found that TLR4 expression was higher in OA cartilage from patients with type 2 diabetes mellitus (T2DM) than that from non-T2DM patients. Similarly, its expression was induced in primary mouse chondrocytes treated with high glucose, which suggests that TLR4 upregulation in T2DM-associated OA cartilage may originate from hyperglycaemia stimulation. We further discovered that TLR4 promoted high glucose-induced catabolic and inflammatory responses in chondrocytes, and mechanistically, these effects could be explained by the exacerbated activation of the transcription factor nuclear factor kappa B (NF-κB) pathway, since its inhibition by Bay 11-7082 abrogated TLR4 effects on high glucose-treated chondrocytes. Taken together, these findings may reveal a promotive role of TLR4 in regulating hyperglycaemia-induced catabolism and inflammation in T2DM-associated OA, and also implicate that TLR4 inhibition might be of therapeutic significance in treating T2DM-associated OA.</description><subject>Animals</subject><subject>Biocompatibility</subject><subject>Biomedical materials</subject><subject>Cartilage</subject><subject>Cartilage diseases</subject><subject>Catabolism</subject><subject>Cells, Cultured</subject><subject>Chondrocytes</subject><subject>Chondrocytes - immunology</subject><subject>Chondrocytes - pathology</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - immunology</subject><subject>Diabetes Mellitus, Type 2 - pathology</subject><subject>Glucose</subject><subject>Glucose - immunology</subject><subject>Health risks</subject><subject>High glucose</subject><subject>Humans</subject><subject>Hyperglycemia</subject><subject>Inflammation</subject><subject>Inflammation - complications</subject><subject>Inflammation - immunology</subject><subject>Inflammation - pathology</subject><subject>Inhibition</subject><subject>Knee</subject><subject>Male</subject><subject>Mice, Inbred C57BL</subject><subject>NF-kappa B - immunology</subject><subject>NF-κB protein</subject><subject>Osteoarthritis</subject><subject>Osteoarthritis - complications</subject><subject>Osteoarthritis - immunology</subject><subject>Osteoarthritis - pathology</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>TLR4 protein</subject><subject>Toll-like receptor 4</subject><subject>Toll-Like Receptor 4 - immunology</subject><subject>Toll-like receptors</subject><subject>Transcription activation</subject><subject>Type 2 diabetes</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1uFDEQRi0EIkPgAGyQJTZsuim37f4RKxIRQIpgE9ZWt13OeHDbjd2NNAfgUhyCM-FoAgsWrKyS3vepXI-Q5wxqBqx9fai9zXUDbKhB1MDYA7JjfTdU0HL2kOwAGlHxBuQZeZLzAQCk7PhjcsZhkLwVckd-3ETvK---Ik2ocVljooIuKc5xxUz37nZPb_2mY8bKBbNpNFSP6zhF7zQdg6EuWD_O81iSx9KRlxhySbpA9T4Gk6I-rqd5DPTTVfXr50VlcMFgMKx0HkPA9JQ8sqPP-Oz-PSdfrt7dXH6orj-__3j59rrSvGdrxbuWW95xO0mhDQzYM2ugGSwHJrlBbvq-m7jmtu9aEGYqsX7QHTZWaylbfk5enXrLB79tmFc1u6zR-zFg3LJqGhBtPzSSFfTlP-ghbimU7QolBBNdL6FQ7ETpFHNOaNWS3Dymo2Kg7hypgyqO1J0jBUIVRyXz4r55m2Y0fxN_pBTgzQnAcorvDpPK2mEop3fF0apMdP-p_w3TWKOB</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Liang, Hongzhi</creator><creator>Wang, Huajun</creator><creator>Luo, Leifeng</creator><creator>Fan, Shuxin</creator><creator>Zhou, Li</creator><creator>Liu, Zhaoshu</creator><creator>Yao, Shujun</creator><creator>Zhang, Xiao</creator><creator>Zhong, Kaihua</creator><creator>Zhao, Hancheng</creator><creator>Zha, Zhengang</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20190701</creationdate><title>Toll-like receptor 4 promotes high glucose-induced catabolic and inflammatory responses in chondrocytes in an NF-κB-dependent manner</title><author>Liang, Hongzhi ; Wang, Huajun ; Luo, Leifeng ; Fan, Shuxin ; Zhou, Li ; Liu, Zhaoshu ; Yao, Shujun ; Zhang, Xiao ; Zhong, Kaihua ; Zhao, Hancheng ; Zha, Zhengang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-3763f373fb54cd09e81fd029f30153de3d887b3c3f87604dbc3889c7e2fcc5563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Biocompatibility</topic><topic>Biomedical materials</topic><topic>Cartilage</topic><topic>Cartilage diseases</topic><topic>Catabolism</topic><topic>Cells, Cultured</topic><topic>Chondrocytes</topic><topic>Chondrocytes - immunology</topic><topic>Chondrocytes - pathology</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - immunology</topic><topic>Diabetes Mellitus, Type 2 - pathology</topic><topic>Glucose</topic><topic>Glucose - immunology</topic><topic>Health risks</topic><topic>High glucose</topic><topic>Humans</topic><topic>Hyperglycemia</topic><topic>Inflammation</topic><topic>Inflammation - complications</topic><topic>Inflammation - immunology</topic><topic>Inflammation - pathology</topic><topic>Inhibition</topic><topic>Knee</topic><topic>Male</topic><topic>Mice, Inbred C57BL</topic><topic>NF-kappa B - immunology</topic><topic>NF-κB protein</topic><topic>Osteoarthritis</topic><topic>Osteoarthritis - complications</topic><topic>Osteoarthritis - immunology</topic><topic>Osteoarthritis - pathology</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>TLR4 protein</topic><topic>Toll-like receptor 4</topic><topic>Toll-Like Receptor 4 - immunology</topic><topic>Toll-like receptors</topic><topic>Transcription activation</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liang, Hongzhi</creatorcontrib><creatorcontrib>Wang, Huajun</creatorcontrib><creatorcontrib>Luo, Leifeng</creatorcontrib><creatorcontrib>Fan, Shuxin</creatorcontrib><creatorcontrib>Zhou, Li</creatorcontrib><creatorcontrib>Liu, Zhaoshu</creatorcontrib><creatorcontrib>Yao, Shujun</creatorcontrib><creatorcontrib>Zhang, Xiao</creatorcontrib><creatorcontrib>Zhong, Kaihua</creatorcontrib><creatorcontrib>Zhao, Hancheng</creatorcontrib><creatorcontrib>Zha, Zhengang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liang, Hongzhi</au><au>Wang, Huajun</au><au>Luo, Leifeng</au><au>Fan, Shuxin</au><au>Zhou, Li</au><au>Liu, Zhaoshu</au><au>Yao, Shujun</au><au>Zhang, Xiao</au><au>Zhong, Kaihua</au><au>Zhao, Hancheng</au><au>Zha, Zhengang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toll-like receptor 4 promotes high glucose-induced catabolic and inflammatory responses in chondrocytes in an NF-κB-dependent manner</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>228</volume><spage>258</spage><epage>265</epage><pages>258-265</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>Diabetes is an independent risk factor for knee osteoarthritis (OA), and hyperglycaemia-induced inflammation is considered to play an important role in their connection. The Toll-like receptor 4 (TLR4) regulates inflammatory responses in several pathological conditions including diabetes and OA. However, its role in diabetes-associated OA is poorly understood. In this study, we found that TLR4 expression was higher in OA cartilage from patients with type 2 diabetes mellitus (T2DM) than that from non-T2DM patients. Similarly, its expression was induced in primary mouse chondrocytes treated with high glucose, which suggests that TLR4 upregulation in T2DM-associated OA cartilage may originate from hyperglycaemia stimulation. We further discovered that TLR4 promoted high glucose-induced catabolic and inflammatory responses in chondrocytes, and mechanistically, these effects could be explained by the exacerbated activation of the transcription factor nuclear factor kappa B (NF-κB) pathway, since its inhibition by Bay 11-7082 abrogated TLR4 effects on high glucose-treated chondrocytes. Taken together, these findings may reveal a promotive role of TLR4 in regulating hyperglycaemia-induced catabolism and inflammation in T2DM-associated OA, and also implicate that TLR4 inhibition might be of therapeutic significance in treating T2DM-associated OA.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>30953645</pmid><doi>10.1016/j.lfs.2019.04.011</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2019-07, Vol.228, p.258-265
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_2204689251
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Biocompatibility
Biomedical materials
Cartilage
Cartilage diseases
Catabolism
Cells, Cultured
Chondrocytes
Chondrocytes - immunology
Chondrocytes - pathology
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - immunology
Diabetes Mellitus, Type 2 - pathology
Glucose
Glucose - immunology
Health risks
High glucose
Humans
Hyperglycemia
Inflammation
Inflammation - complications
Inflammation - immunology
Inflammation - pathology
Inhibition
Knee
Male
Mice, Inbred C57BL
NF-kappa B - immunology
NF-κB protein
Osteoarthritis
Osteoarthritis - complications
Osteoarthritis - immunology
Osteoarthritis - pathology
Risk analysis
Risk factors
TLR4 protein
Toll-like receptor 4
Toll-Like Receptor 4 - immunology
Toll-like receptors
Transcription activation
Type 2 diabetes
title Toll-like receptor 4 promotes high glucose-induced catabolic and inflammatory responses in chondrocytes in an NF-κB-dependent manner
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T16%3A44%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toll-like%20receptor%204%20promotes%20high%20glucose-induced%20catabolic%20and%20inflammatory%20responses%20in%20chondrocytes%20in%20an%20NF-%CE%BAB-dependent%20manner&rft.jtitle=Life%20sciences%20(1973)&rft.au=Liang,%20Hongzhi&rft.date=2019-07-01&rft.volume=228&rft.spage=258&rft.epage=265&rft.pages=258-265&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2019.04.011&rft_dat=%3Cproquest_cross%3E2244147850%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2244147850&rft_id=info:pmid/30953645&rft_els_id=S0024320519302619&rfr_iscdi=true